Yi Shen

1.2k total citations
41 papers, 931 citations indexed

About

Yi Shen is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Yi Shen has authored 41 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Cell Biology and 11 papers in Cancer Research. Recurrent topics in Yi Shen's work include Aldose Reductase and Taurine (8 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (8 papers). Yi Shen is often cited by papers focused on Aldose Reductase and Taurine (8 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (8 papers). Yi Shen collaborates with scholars based in China, United States and Iraq. Yi Shen's co-authors include Deliang Cao, Jing Hua, Chenfei Huang, Yiwen Bu, Zhuangzhuang Cong, Zhisheng Jiang, Haiwei Wu, Hairong Huang, Jun Ma and Xiaokun Li and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical Journal and Clinical Cancer Research.

In The Last Decade

Yi Shen

38 papers receiving 925 citations

Peers

Countries citing papers authored by Yi Shen

Since Specialization

Citations

This map shows the geographic impact of Yi Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Shen more than expected).

Fields of papers citing papers by Yi Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Shen. The network helps show where Yi Shen may publish in the future.

Co-authorship network of co-authors of Yi Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Shen. A scholar is included among the top collaborators of Yi Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Shen. Yi Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	M2 macrophage-targeted metal-polyphenol networks (MPNs) for OPN siRNA delivery and idiopathic pulmonary fibrosis therapy 2025 ·Journal of Controlled Release ·(unknown), (unknown), Jie Ji, Yuxin Liu, Xiaodan Jiao, Xiaoyang Li, Yi Shen, Hao Hong, Xiaodong Han	0
2	994MO The updated report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/Rα payloads, in patients with advanced solid tumors 2024 ·Annals of Oncology ·Yi Shen, (unknown), Aiping Qin, Yiting Qiu, Fang Tang, Xinling Liang, Ye Li, Qunyou Tan, Ronghua Zhao, Xue Bai, (unknown)	0
3	Exosomal MALAT1 promotes the proliferation of esophageal squamous cell carcinoma through glyoxalase 1-dependent methylglyoxal removal 2024 ·Non-coding RNA Research ·Li‐Wen Hu, Kai Xie, (unknown), (unknown), Zhisheng Jiang, (unknown), Yifei Diao, Jing Luo, Xinyue Yao, Yi Shen	9
4	Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis 2023 ·Journal of Translational Medicine ·Jie Ji, (unknown), (unknown), Tian Xie, (unknown), (unknown), Yi Shen, Xiaodong Han	25
5	83P The updated report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/RA payloads, in patients with advanced solid tumors 2023 ·Annals of Oncology ·Yi Shen, (unknown), Aiping Qin, Yiting Qiu, Fang Tang, Xinling Liang, Ye Li, (unknown), Ronghua Zhao, Xue Bai, (unknown)	2
6	Regulation of IncRNA ZNF667-AS1 in Proliferation and Invasion of Esophageal Squamous Cell Carcinoma Cells via Mediating ceRNA Network 2022 ·Critical Reviews in Eukaryotic Gene Expression ·Lei Wei, (unknown), (unknown), Kang Wang, Hairong Huang, Yi Shen	3
7	Discovery and validation of extracellular vesicle‐associated miRNAs as noninvasive detection biomarkers for early‐stage non‐small‐cell lung cancer 2020 ·Molecular Oncology ·(unknown), Xiaoyu Ding, (unknown), Jing Wang, Wanqing Zhou, Xiangdong Wang, (unknown), Yi Shen, (unknown), Jing Li, Chen‐Yu Zhang, Cheng Wang	32
8	<p>FAM111B, a direct target of p53, promotes the malignant process of lung adenocarcinoma</p> 2019 ·OncoTargets and Therapy ·Haijun Sun, Kaichao Liu, Jianfeng Huang, Qi Sun, Chenye Shao, Jing Luo, Lin Xu, Yi Shen, Binhui Ren	39
9	HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription ofCASP3 2017 ·Cancer Science ·Jing Luo, Zhongqiu Wang, Jianfeng Huang, Yu Yao, Qi Sun, Jie Wang, Yi Shen, (unknown), Binhui Ren	23
10	The outcome of muscular vein thrombosis after knee and hip arthroplasty 2016 ·Zhonghua guke zazhi ·Yao Yao, Junlan Qiu, Liang Qiao, (unknown), Zhihong Xu, Dongquan Shi, Jin Dai, Long Xue, Zhiming Jiang, Yi Shen, (unknown), Weiwei Zhang, Qing Jiang	1
11	Protective effect of melatonin on the development of abdominal aortic aneurysm in a rat model 2016 ·Journal of Surgical Research ·(unknown), Zhuangzhuang Cong, Shuangying Hao, Li Peng, Hairong Huang, Yi Shen, Kuanyu Li, Jing Hua	11
12	Impaired Self-Renewal and Increased Colitis and Dysplastic Lesions in Colonic Mucosa of AKR1B8-Deficient Mice 2014 ·Clinical Cancer Research ·Yi Shen, Jun Ma, Ruilan Yan, Hongyan Ling, Xiaoning Li, Wancai Yang, John Gao, Chenfei Huang, Yiwen Bu, Yu Cao, Yingchun He, (unknown), Xuyu Zu, Jianghua Liu, Mei Huang, William F. Stenson, Duan‐Fang Liao, Deliang Cao	49
13	Quercetin reduces oxidative stress and inhibits activation of c-Jun N-terminal kinase/activator protein-1 signaling in an experimental mouse model of abdominal aortic aneurysm 2013 ·Molecular Medicine Reports ·Lian Wang, Xiaofeng Cheng, Hao Li, Fang Qiu, Nan Yang, Bo Wang, (unknown), Haiwei Wu, Yi Shen, (unknown), Jing Hua	39
14	Erythropoietin attenuates cardiopulmonary bypass-induced renal inflammatory injury by inhibiting nuclear factor-kappa B P65 expression 2012 ·European Journal of Pharmacology ·Gaoming Wang, Hairong Huang, Haiwei Wu, Chen Wu, Yanhui Xu, Lian Wang, (unknown), Changtian Wang, Yi Shen, Demin Li, Jing Hua	16
15	AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker 2012 ·International Journal of Cancer ·Jun Ma, Dixian Luo, Chenfei Huang, Yi Shen, Yiwen Bu, Stephen Markwell, John Gao, Jianghua Liu, Xuyu Zu, Zhe Cao, (unknown), Fengmin Lu, Duan‐Fang Liao, Deliang Cao	96
16	Recombinant Human Erythropoietin Pretreatment Attenuates Heart Ischemia-Reperfusion Injury in Rats by Suppressing the Systemic Inflammatory Response 2010 ·Transplantation Proceedings ·Yi Shen, Yiwen Wang, (unknown), Congyan Wang, Biao Xu, Guohua Dong, Hairong Huang, Jing Hua	18
17	Simvastatin attenuates cardiopulmonary bypass-induced myocardial inflammatory injury in rats by activating peroxisome proliferator-activated receptor γ 2010 ·European Journal of Pharmacology ·Yi Shen, Haiwei Wu, Changtian Wang, (unknown), Hairong Huang, Jing Hua, Demin Li	43
18	Thiol-disulfide exchanges modulate aldo–keto reductase family 1 member B10 activity and sensitivity to inhibitors 2010 ·Biochimie ·Yi Shen, Linlin Zhong, Stephen Markwell, Deliang Cao	25
19	Simvastatin Suppresses Lung Inflammatory Response in a Rat Cardiopulmonary Bypass Model 2007 ·The Annals of Thoracic Surgery ·(unknown), Yi Shen, Hao Liu, Guohua Dong, (unknown), Jing Hua	23
20	Concordant expression of proto‐oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma 2007 ·Tissue Antigens ·Xia Mao, (unknown), Yi Shen, Lianhong Xu, (unknown), Fengqin Miao, Wei Xie	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact